Asset Purchase and Merger Agreements - Checkpoint Transaction (Details) - USD ($) |
1 Months Ended | 3 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Mar. 31, 2025 |
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Business Combination [Line Items] | ||||
| Gain from deconsolidation of subsidiary | $ 27,100,000 | |||
| Revenue | 15,921,000 | $ 13,139,000 | ||
| Checkpoint Merger | ||||
| Business Combination [Line Items] | ||||
| Proceeds from sale of subsidiary interests | $ 28,000,000 | |||
| Royalty revenue | ||||
| Business Combination [Line Items] | ||||
| Revenue | 77,000 | |||
| Checkpoint Merger | ||||
| Business Combination [Line Items] | ||||
| Milestone paid | $ 0 | |||
| Checkpoint Merger | Checkpoint Merger | Sun Pharmaceutical Industries, Inc. | ||||
| Business Combination [Line Items] | ||||
| Stock purchase, price per share | $ 4.1 | $ 4.1 | ||
| Maximum contingent consideration per each outstanding share | $ 0.7 | $ 0.7 | ||
| Checkpoint Merger | Royalty revenue | ||||
| Business Combination [Line Items] | ||||
| Percentage of royalty on future net sales | 2.50% | |||
| X | ||||||||||
- Definition Amount of contingent consideration recognized for each share of outstanding stock pursuant to a merger agreement. No definition available.
|
| X | ||||||||||
- Definition Amount of milestone paid No definition available.
|
| X | ||||||||||
- Definition Percentage of royalty on future net sales granted to the company. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|